BlackRock Portfolio holdings
AUM $5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
-17.56%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$2.03T
AUM Growth
-$561B
(-22%)
Cap. Flow
+$1.59B
Cap. Flow
% of AUM
0.08%
Top 10 Holdings %
Top 10 Hldgs %
17.78%
Holding
5,099
New
121
Increased
1,857
Reduced
2,479
Closed
149
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.53B |
| 2 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$1.09B |
| 3 |
Prologis
PLD
|
+$931M |
| 4 |
SPDR Gold Trust
GLD
|
+$798M |
| 5 |
Centene
CNC
|
+$777M |
Top Sells
| 1 |
LPT
Liberty Property Trust
LPT
|
+$1.24B |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$1.19B |
| 3 |
MDCO
Medicines Co
MDCO
|
+$1.03B |
| 4 |
Apple
AAPL
|
+$785M |
| 5 |
AT&T
T
|
+$561M |
Sector Composition
| 1 | Technology | 20.34% |
| 2 | Healthcare | 15.21% |
| 3 | Financials | 12.82% |
| 4 | Consumer Discretionary | 9.83% |
| 5 | Communication Services | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Arrow Financial
AROW
$481M
| $31M | ﹤0.01% |
1,252,912
+10,035
| +0.8% | +$248K |
|
2327
Spok Holdings
SPOK
$363M
| $31M | ﹤0.01% |
2,900,964
-66,974
| -2% | -$716K |
|
2328
iShares Emerging Markets Dividend ETF
DVYE
$929M
| $30.9M | ﹤0.01% |
1,099,311
+158,665
| +17% | +$4.47M |
|
2329
Vericel Corp
VCEL
$1.61B
| $30.9M | ﹤0.01% |
3,374,597
+123,026
| +4% | +$1.13M |
|
2330
Conduent
CNDT
$433M
| $30.9M | ﹤0.01% |
12,610,222
-141,631
| -1% | -$347K |
|
2331
Evolent Health
EVH
$1.02B
| $30.9M | ﹤0.01% |
5,687,377
-680,962
| -11% | -$3.7M |
|
|
UMH
2332
UMH Properties
UMH
$1.29B
| $30.9M | ﹤0.01% |
2,841,753
-14,796
| -0.5% | -$161K |
|
|
BCEL
2333
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $30.8M | ﹤0.01% |
1,863,589
+551,189
| +42% | +$9.12M |
|
|
NWLI
2334
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $30.8M | ﹤0.01% |
178,911
+3,881
| +2% | +$668K |
|
|
XENT
2335
DELISTED
Intersect ENT, Inc
XENT
| $30.7M | ﹤0.01% |
2,594,715
-54,015
| -2% | -$640K |
|
|
ARCH
2336
DELISTED
Arch Resources, Inc.
ARCH
| $30.7M | ﹤0.01% |
1,063,145
-104,345
| -9% | -$3.02M |
|
|
SHYF
2337
DELISTED
The Shyft Group
SHYF
| $30.7M | ﹤0.01% |
2,378,681
-33,748
| -1% | -$436K |
|
2338
QCR Holdings
QCRH
$1.31B
| $30.7M | ﹤0.01% |
1,133,002
+49,235
| +5% | +$1.33M |
|
|
QTS.PRB
2339
DELISTED
QTS Realty Trust, Inc. 6.50% Series B Cumulative Convertible Perpetual Preferred Stock
QTS.PRB
| $30.7M | ﹤0.01% |
238,486
-10,797
| -4% | -$1.39M |
|
|
GMRE
2340
Global Medical REIT
GMRE
$513M
| $30.6M | ﹤0.01% |
3,022,953
+420,388
| +16% | +$4.25M |
|
2341
Core Laboratories
CLB
$584M
| $30.6M | ﹤0.01% |
2,954,605
-226,384
| -7% | -$2.34M |
|
2342
Movado Group
MOV
$438M
| $30.5M | ﹤0.01% |
2,580,902
-42,471
| -2% | -$502K |
|
2343
Ecovyst
ECVT
$1.06B
| $30.5M | ﹤0.01% |
2,795,143
+53,646
| +2% | +$585K |
|
|
TECX
2344
Tectonic Therapeutic, Inc. Common Stock
TECX
$321M
| $30.5M | ﹤0.01% |
163,129
+13,246
| +9% | +$2.47M |
|
2345
Team
TISI
$83.8M
| $30.4M | ﹤0.01% |
468,387
-12,928
| -3% | -$840K |
|
|
ATHX
2346
DELISTED
Athersys, Inc. Common Stock
ATHX
| $30.4M | ﹤0.01% |
405,399
+4,926
| +1% | +$369K |
|
2347
Daktronics
DAKT
$1.15B
| $30.3M | ﹤0.01% |
6,139,054
-74,814
| -1% | -$369K |
|
2348
VEON
VEON
$3.71B
| $30.3M | ﹤0.01% |
801,694
-494,722
| -38% | -$18.7M |
|
|
HIBB
2349
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $30.3M | ﹤0.01% |
2,767,618
-116,118
| -4% | -$1.27M |
|
2350
Corbus Pharmaceuticals
CRBP
$113M
| $30.2M | ﹤0.01% |
192,415
+12,008
| +7% | +$1.89M |
|